Cinolazepam

Last updated
Cinolazepam
Cinolazepam.svg
Cinolazepam3d.png
Clinical data
Trade names Gerodorm 40mg
AHFS/Drugs.com cinolazepam
Dependence
liability 		High
Addiction
liability 		Medium
Routes of
administration 		Oral
ATC code
Legal status
Legal status
  • US:Unscheduled
  • EU:Prescription drug
Pharmacokinetic data
Bioavailability 90–100%
Metabolism Hepatic
Onset of action 30 minutes to 1 hour
Elimination half-life 9 hours
Duration of action 9 hours
Excretion Renal
Identifiers
  • (RS)-3-[9-Chloro-6-(2-fluorophenyl)-4-hydroxy-3-oxo-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-2-yl]propanenitrile
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C18H13ClFN3O2
Molar mass 357.77 g·mol−1
3D model (JSmol)
Chirality Racemic mixture
  • FC1=CC=CC=C1C2=NC(C(N(CCC#N)C3=C2C=C(C=C3)Cl)=O)O
  • InChI=1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2 Yes check.svgY
  • Key:XAXMYHMKTCNRRZ-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Cinolazepam [1] (marketed under the brand name Gerodorm) [2] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as a hypnotic.

It was patented in 1978 and came into medical use in 1992. [3] Cinolazepam is mainly used in Romania and Slovakia; it not approved for sale in the United States or Canada.

References

  1. ↑ US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
  2. ↑ Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006.
  3. ↑ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 530. ISBN   9783527607495.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.